ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Esoprax 20 mg, magensaftresistente Tabletten - 14
66321001 Drossapharm AG
Esoprax 20 mg, magensaftresistente Tabletten12.07.2017
  12.07.2017
Esomeprazole (A02BC05) 
WHO-DDD 
04.99.14
04.99. 
B  
No 
IPCI
5.54  
k.A.14.55
7680663210010Synthetika
7545671 
Composition
esomeprazolum 20 mg ut esomeprazolum magnesicum dihydricum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, talcum, triethylis citras, hypromellosum, sacchari sphaerae corresp. saccharum max. 5.62 mg, magnesii stearas, hydroxypropylcellulosum, glyceroli monostearas 40-55, polysorbatum 80, cellulosum microcristallinum, povidonum K 30, macrogolum 6000, crospovidonum, natrii stearylis fumaras corresp. natrium 0.04 mg, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (rubrum), E 172 (flavum), pro compresso obducto.
Packungsbestandteile
Gastric juice resistant tablets 
 
Active AgentDose
Esomeprazol20 mg
BAG: Active AgentDose
Esomeprazol20 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Rubrum)  
Acidi Methacrylici  
Cellulosum Microcristallinum  
Crospovidonum  
E 171 color.
E 172 color.
Ethylis Acrylatis Polymerisatum  
Glyceroli Monostearas40-55 
Hydroxypropylcellulosum  
Hypromellosum Überzug
Macrogol400  
Magnesii Stearas  
Natrii Stearylis Fumaras  
Polysorbatum 80  
Povidonum K30  
Pro Compresso Obducto  
Sacchari Sphaerae  
Talcum  
Triethylis Citras  
 
Source
Data was imported : 07.08.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home